HKU Scholars Hub: Browsing DSpace

Browsing by Author Verma, S

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 13 of 13

	Title	Author(s)	Issue Date
	Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes Journal:Schizophrenia Research	Youn, S Phillips, LJ Amminger, GP Berger, G Chen, EYH de Haan, L Hartmann, JA Hickie, IB Lavoie, S Markulev, C McGorry, PD Mossaheb, N Nieman, DH Nordentoft, M Riecher-Rössler, A Schäfer, MR Schlögelhofer, M Smesny, S Thompson, A Verma, S Yuen, HP Yung, AR Nelson, B	2020
	Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial Journal:Schizophrenia Research	Mallawaarachchi, SR Amminger, GP Farhall, J Bolt, LK Nelson, B Yuen, HP McGorry, PD Markulev, C Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Allott, KA	2020
	Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people Journal:Schizophrenia Research	Alqarni, A Mitchell, TW McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Berger, M Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Amminger, GP Meyer, BJ	2020
	Distress related to attenuated psychotic symptoms: Static and dynamic association with transition to psychosis, non-remission and transdiagnostic symptomatology in clinical high-risk patients in an international intervention trial Journal:Schizophrenia Bulletin Open	Nelson, B Yuen, HP Amminger, GP Berger, G Chen, EYH de Haan, L Hartmann, JA Hickie, IB Lavoie, S Markulev, C Mossaheb, N Nieman, DH Nordentoft, M Polari, A Riecher-Rössler, A Schäfe, MR Schlögelhofer, M Smesny, S Tedja, A Thompson, A Verma, S Yung, AR McGorry, PD	2020
	Do schizotypal or borderline personality disorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in patients at high clinical risk? Journal:Schizophrenia Research	Hadar, H Zhang, H Phillips, LJ Amminger, GP Berger, GE Chen, EYH de Haan, L Hartmann, JA Hickie, IB Lavoie, S Markulev, C McGorry, PD Mossaheb, N Nieman, DH Nordentoft, M Riecher-Rössler, A Schäfer, MR Schlögelhofer, M Smesny, S Thompson, A Verma, S Yuen, HP Yung, AR Nelson, B	2020
	Empagliflozin does not affect left ventricular diastolic function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial Journal:Acta Diabetologica	Rai, A Connelly, KA Verma, S Mazer, CD Teoh, H Ng, MY Roifman, I Quan, A Pourafkari, M Jimenez-Juan, L Ramanan, V Ge, Y Deva, DJ Yan, AT	2022
	Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial Journal:Schizophrenia Research	Bolt, LK Amminger, GP Farhall, J McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Allott, KA	2019
	Omega‐3 fatty acids and neurocognitive ability in young people at ultra‐high risk for psychosis Journal:Early Intervention in Psychiatry	McLaverty, A Allott, KA Berger, M Hester, R McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher‐Rössler, A Verma, S Thompson, A Yung, AR Amminger, GP	2020
	Perception towards medication discontinuation in remitted first-episode psychosis among clinicians Proceeding/Conference:Early Intervention in Psychiatry	Verma, S Chan, CT Hui, CLM Chen, EYH	2018
	Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial Journal:Frontiers in Psychiatry	Berger, M Nelson, B Markulev, C Yuen, HP Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Mitchell, TW Meyer, BJ Thompson, A Yung, AR McGorry, PD Amminger, GP	2019
	Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis Journal:Schizophrenia Research	Alqarni, A Mitchell, TW McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Berger, M Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Meyer, BJ Amminger, GP	2020
	The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis Journal:Biological Psychiatry	Amminger, GP Nelson, B Markulev, C Yuen, HP Schäfer, MR Berger, M Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler,, A Verma, S Thompson, A Yung, AR McGorry, PD	2020
	The Role of Information and Communication Technologies(ICTs) in Early Childhood Education in Jamaica: Early Observations from a One-Laptop-Per-Child Pilot Project Journal:Caribbean Journal of Education	Bailey, A McNaughton, M MUSCHETTE, N Verma, S	2015

Showing results 1 to 13 of 13